Navigation Links
BioPharm America Offers More High-Level Opportunities for Networking With Global Life Science Executives at 2017 Edition
Date:7/10/2017

CARLSBAD, Calif., July 10, 2017 /PRNewswire/ -- The tenth annual BioPharm America™ will take place in Boston, MA at the Sheraton Boston Hotel, September 26–27. The event will deliver unequaled value and unparalleled access to global decision makers and innovative biotech startup companies. The event is expected to draw 800+ life science leaders during two impactful days. BioPharm America is now part of Biotech Week Boston, and provides delegates with additional networking opportunities with 4,500+ life science industry influencers participating in 8+ Boston-based events hosted by KNect365 and partners, September 25–28.

BioPharm America 2017
BioPharm America 2017

"BioPharm America is a unique partnering event that enables the most cutting edge biotech companies to break into the inner circle of life science dealmaking," said Anna Chrisman, Group Managing Director, EBD Group. "There is no other event that captures the energy and excitement of Boston's startup culture to infuse global partnerships for drug discovery."

Biotech startups have an expanded presence at the event, and will have many opportunities to find best fit partners for every phase of development, from discovery and research, to early clinical development. In addition to company presentations, biotech companies will participate in a Startup Program that includes a Startup Pitch Competition with judges comprised of business development execs, venture capitalists, and industry experts.

Leading pharma executives and investors headlining the program include:

  • Christiana Bardon – Managing Director, Oncology Impact Fund, MPM Capital; Portfolio Manager, Burrage Capital
  • Philip Gotwals, Head, Search and Evaluation Strategic Alliances, Novartis Institutes for BioMedical Research, Inc.
  • Kevin Johnson – Co-Founder and Partner, Medicxi
  • Peter Kolchinsky – Managing Director, RA Capital Management, LLC
  • Nilesh Kumar – Partner, Novo Ventures
  • Lizabeth Leveille – Associate VP and Head, Boston Innovation Hub, BD&L, Merck
  • Eddie Martucci – Co-Founder and CEO at Akili Interactive Labs; VP at PureTech Ventures
  • Rick Pierce – Founder FEP Capital Advisors
  • Chandra Ramanathan – VP and Head, East Coast Innovation Center, Bayer
  • Barbara Russell – Managing Director, Detwiler Fenton
  • Aaron Schwartz – Director, R&D Innovation Sourcing, Novo Nordisk
  • Rafaèle Tordjman – Special Advisor, Sofinnova Partners.

BioPharm America creates a robust exchange among hundreds of executives from venture capital firms, major pharmaceutical companies, academic institutions, patient advocacy groups, and biotechnology companies of every size and stage, from mature to startup. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development.

Additional links and information:
Follow BioPharm America™ on Twitter:  @EBDGroup (hashtag: #BioPharmUSA).

About EBD Group
EBD Group is the leading partnering firm for the global life science industry.

EBD Group's conferences are run with the support of leading corporations and international trade associations and include:

Tune into EBD Group's Insight for timely coverage of news that influences the business strategies of the life science industry.

For more information please visit www.ebdgroup.com.

Media Contact:

Erin Righetti
760-930-0500
167080@email4pr.com

View original content with multimedia:http://www.prnewswire.com/news-releases/biopharm-america-offers-more-high-level-opportunities-for-networking-with-global-life-science-executives-at-2017-edition-300484936.html


'/>"/>
SOURCE EBD Group
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Regen BioPharma, Inc. Sees Success in Its Pre-Clinical Small Molecule Optimization Program for NR2F6
2. Research Reports Initiation on Biotech Stocks -- Sarepta Therapeutics, Galena Biopharma, Anthera Pharma, and Clovis Oncology
3. MGB Biopharma Closes $1 million Financing Round to Finance Manufacturing of MGB-BP-3 for Phase II Study in Clostridium difficile-Associated Disease (CDAD)
4. Provectus Biopharmaceuticals Announces Terms Of Definitive Financing Commitment
5. Regen BioPharma Restructures Management Stock Compensation
6. Yisheng Biopharma to Present at BioPharma Asia Convention 2017 in Singapore
7. PDL BioPharma to Present at the Oppenheimer 27th Annual Healthcare Conference
8. LSK BioPharma Announces Enrollment of First Patient in Phase 3 Apatinib Trial in Gastric Cancer
9. BioPharmX Society of Toxicology Poster Suggests Promise of BPX-01 as Topical Acne Therapy, Highlights Safety
10. First Adaptive Bioproduction Suite to Debut at Premier BioPharma Event
11. CTI BioPharma Reports Fourth Quarter and Full Year 2016 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare product ... training aide "cprCUBE" on Kickstarter. The device will educate ... cardiac arrests with better efficiency compared to the dated ... real-time feedback on efficacy of the compression for a ... has a goal to raise $5,000. ...
(Date:10/4/2017)... , Oct. 4, 2017 OBP ... self-contained, illuminating medical devices, today announced regulatory approval ... Surveillance Agency (or Agência Nacional de Vigilância Sanitária ... single-use, cordless surgical retractor with integrated LED light ... access, illumination and exposure of a tissue pocket ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):